297 related articles for article (PubMed ID: 33424849)
1. Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.
Crossland RE; Perutelli F; Bogunia-Kubik K; Mooney N; Milutin Gašperov N; Pučić-Baković M; Greinix H; Weber D; Holler E; Pulanić D; Wolff D; Dickinson AM; Inngjerdingen M; Grce M
Front Immunol; 2020; 11():602547. PubMed ID: 33424849
[TBL] [Abstract][Full Text] [Related]
2. Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation.
Partanen J; Hyvärinen K; Bickeböller H; Bogunia-Kubik K; Crossland RE; Ivanova M; Perutelli F; Dressel R
Front Immunol; 2020; 11():575492. PubMed ID: 33193367
[TBL] [Abstract][Full Text] [Related]
3. The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.
Ren HG; Adom D; Paczesny S
Expert Rev Clin Immunol; 2018 May; 14(5):389-404. PubMed ID: 29629613
[TBL] [Abstract][Full Text] [Related]
4. Recent advances and research progress in biomarkers for chronic graft versus host disease.
Ji R; Li Y; Huang R; Xiong J; Wang X; Zhang X
Crit Rev Oncol Hematol; 2023 Jun; 186():103993. PubMed ID: 37061073
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in chronic graft-versus-host disease.
Rozmus J; Schultz KR
Expert Rev Hematol; 2011 Jun; 4(3):329-42. PubMed ID: 21668397
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications for biomarkers of acute and chronic graft-versus-host disease.
Levine JE; Paczesny S; Sarantopoulos S
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S116-24. PubMed ID: 22226094
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study.
Łacina P; Crossland RE; Wielińska J; Czyż A; Szeremet A; Ussowicz M; Wróbel T; Dickinson AM; Bogunia-Kubik K
Adv Clin Exp Med; 2023 May; 32(5):539-544. PubMed ID: 36398373
[TBL] [Abstract][Full Text] [Related]
8. Global Metabolomics in Allogeneic Hematopoietic Cell Transplantation Recipients Discordant for Chronic Graft-versus-Host Disease.
Lynch Kelly D; Farhadfar N; Starkweather A; Garrett TJ; Yao Y; Wingard JR; Mahmud I; Menzies V; Patel P; Alabasi KM; Lyon D
Biol Blood Marrow Transplant; 2020 Oct; 26(10):1803-1810. PubMed ID: 32592859
[TBL] [Abstract][Full Text] [Related]
9. Biomarker Panel for Chronic Graft-Versus-Host Disease.
Yu J; Storer BE; Kushekhar K; Abu Zaid M; Zhang Q; Gafken PR; Ogata Y; Martin PJ; Flowers ME; Hansen JA; Arora M; Cutler C; Jagasia M; Pidala J; Hamilton BK; Chen GL; Pusic I; Lee SJ; Paczesny S
J Clin Oncol; 2016 Aug; 34(22):2583-90. PubMed ID: 27217465
[TBL] [Abstract][Full Text] [Related]
10. A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation.
Chirumbolo G; Dicataldo M; Barone M; Storci G; De Matteis S; Laprovitera N; Sinigaglia B; Barbato F; Maffini E; Cavo M; Bonifazi F; Arpinati M
Transplant Cell Ther; 2023 May; 29(5):302.e1-302.e8. PubMed ID: 36796518
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].
Cheng XJ; Ji R; Huan RH; Huang SQ; Fan W; Zhao YC; Yuan RD; Wang XQ; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):242-248. PubMed ID: 38716595
[No Abstract] [Full Text] [Related]
12. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
Front Immunol; 2019; 10():1879. PubMed ID: 31507582
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for acute and chronic graft versus host disease: state of the art.
Giaccone L; Faraci DG; Butera S; Lia G; Di Vito C; Gabrielli G; Cerrano M; Mariotti J; Dellacasa C; Felicetti F; Brignardello E; Mavilio D; Bruno B
Expert Rev Hematol; 2021 Jan; 14(1):79-96. PubMed ID: 33297779
[TBL] [Abstract][Full Text] [Related]
14. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease.
Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T
Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430
[TBL] [Abstract][Full Text] [Related]
15. Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review.
Milosevic E; Babic A; Iovino L; Markovic M; Grce M; Greinix H
Front Immunol; 2022; 13():1033263. PubMed ID: 36389657
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Kariminia A; Holtan SG; Ivison S; Rozmus J; Hebert MJ; Martin PJ; Lee SJ; Wolff D; Subrt P; Abdossamadi S; Sung S; Storek J; Levings M; Aljurf M; Arora M; Cutler C; Gallagher G; Kuruvilla J; Lipton J; Nevill TJ; Newell LF; Panzarella T; Pidala J; Popradi G; Szwajcer D; Tay J; Toze CL; Walker I; Couban S; Storer BE; Schultz KR
Blood; 2016 Jun; 127(24):3082-91. PubMed ID: 27020088
[TBL] [Abstract][Full Text] [Related]
17. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
[TBL] [Abstract][Full Text] [Related]
18. Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death.
Logan BR; Fu D; Howard A; Fei M; Kou J; Little MR; Adom D; Mohamed FA; Blazar BR; Gafken PR; Paczesny S
J Clin Invest; 2023 Aug; 133(15):. PubMed ID: 37526081
[TBL] [Abstract][Full Text] [Related]
19. Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.
Hao B; Gao S; Sang YW; Wang L; Meng XQ; You JY
J Zhejiang Univ Sci B; 2019 Oct.; 20(10):849-860. PubMed ID: 31489804
[TBL] [Abstract][Full Text] [Related]
20. CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Greinix HT; Kuzmina Z; Weigl R; Körmoczi U; Rottal A; Wolff D; Kralj M; Kalhs P; Mitterbauer M; Rabitsch W; Edinger M; Holler E; Pickl WF
Biol Blood Marrow Transplant; 2015 Feb; 21(2):250-8. PubMed ID: 25460358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]